Exchange
Hypotheses
Top-ranked hypotheses by composite score. Filter by lifecycle status, disease, or target gene; sort by score or recency. Click a row to open evidence, scoring detail, and any live prediction markets referencing it.
7
total hypotheses
| # | Hypothesis | Target gene | Status | Composite | Updated | |
|---|---|---|---|---|---|---|
| 1 | CYP46A1 Small Molecule Activator Therapy h-var-32c4875adb | CYP46A1 | validated | 0.819 | 2026-05-13 | Open → |
| 2 | CYP46A1-Mediated Cholesterol Reduction Prevents eIF2α-Driven Translation Stalli… h-var-bcf6a16044 | CYP46A1 | validated | 0.819 | 2026-05-13 | Open → |
| 3 | CYP46A1 Overexpression Gene Therapy h-2600483e | CYP46A1 | promoted | 0.768 | 2026-05-16 | Open → |
| 4 | CYP46A1 Suppression for Tau-Mediated Neurodegeneration h-var-1dc420e7d8 | CYP46A1 | proposed | 0.642 | 2026-05-16 | Open → |
| 5 | CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Rever… h-var-3fbcfc0e6c | CYP46A1 | proposed | 0.555 | 2026-05-16 | Open → |
| 6 | CYP46A1 Inhibition Therapy for Neurodegeneration h-var-42910c6bed | CYP46A1 | promoted | 0.380 | 2026-05-13 | Open → |
| 7 | Focused Ultrasound-Enhanced CYP46A1 Gene Therapy for Neurodegeneration h-var-d1632ebb0f | CYP46A1 | promoted | 0.380 | 2026-05-13 | Open → |